Browsing byAuthorTraini, D

Jump to a point in the index:
Showing results 1 to 20 of 56  next >
Issue DateTitleAuthor(s)
2022-06Timothy Grass Pollen Induces Spatial Reorganisation of F-Actin and Loss of Junctional Integrity in Respiratory Cells.Bradbury, P; Cidem, A; Mahmodi, H; Davies, JM; Spicer, PT; Prescott, SW; Kabakova, I; Ong, HX; Traini, D
2022-04-02Application of Micro-Engineered Kidney, Liver, and Respiratory System Models to Accelerate Preclinical Drug Testing and Development.Gholizadeh, H; Cheng, S; Kourmatzis, A; Xing, H; Traini, D; Young, PM; Ong, HX
2022-02-22Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract.Zhang, Y; Almazi, JG; Ong, HX; Johansen, MD; Ledger, S; Traini, D; Hansbro, PM; Kelleher, AD; Ahlenstiel, CL
2021-08-05How Do Mechanics Guide Fibroblast Activity? Complex Disruptions during Emphysema Shape Cellular Responses and Limit Research.Leslie, MN; Chou, J; Young, PM; Traini, D; Bradbury, P; Ong, HX
2021-07-05Tobramycin and Colistin display anti-inflammatory properties in CuFi-1 cystic fibrosis cell line.Sheikh, Z; Bradbury, P; Reekie, TA; Pozzoli, M; Robinson, PD; Kassiou, M; Young, PM; Ong, HX; Traini, D
2021-06Real-time quantitative monitoring of in vitro nasal drug delivery by a nasal epithelial mucosa-on-a-chip model.Gholizadeh, H; Ong, HX; Bradbury, P; Kourmatzis, A; Traini, D; Young, P; Li, M; Cheng, S
2021-03-01Development and in vitro characterization of a novel pMDI diclofenac formulation as an inhalable anti-inflammatory therapy for cystic fibrosis.Sheikh, Z; Gomes Dos Reis, L; Bradbury, P; Meneguzzo, G; Scalia, S; Young, PM; Ong, HX; Traini, D
2020-11An in vitro model for assessing drug transport in cystic fibrosis treatment: Characterisation of the CuFi-1 cell line.Sheikh, Z; Bradbury, P; Pozzoli, M; Young, PM; Ong, HX; Traini, D
2020-08-21Properties of rapamycin solid lipid nanoparticles for lymphatic access through the lungs & part I: the effect of size.Landh, E; M Moir, L; Bradbury, P; Traini, D; M Young, P; Ong, HX
2020-04Effect of continuous positive airway pressure treatment on permeability, inflammation and mucus production of human epithelial cells.Grau-Bartual, S; Al-Jumaily, AM; Young, PM; Traini, D; Ghadiri, M
2020-01Modifying and Integrating <i>in vitro</i> and <i>ex vivo</i> Respiratory Models for Inhalation Drug Screening.Cidem, A; Bradbury, P; Traini, D; Ong, HX
2018-10-01A Simple and Rapid Method for Deposition and Measurement of Drug Transport Across Air Interface Respiratory EpitheliaHaghi, M; Young, PM; Traini, D
2018-08-25Development of ciprofloxacin-loaded poly(vinyl alcohol) dry powder formulations for lung deliverySilva, DM; Paleco, R; Traini, D; Sencadas, V
2018-08-01Repurposing of statins via inhalation to treat lung inflammatory conditionsBradbury, P; Traini, D; Ammit, AJ; Young, PM; Ong, HX
2017-09-02Development of a Soluplus budesonide freeze-dried powder for nasal drug deliveryPozzoli, M; Traini, D; Young, PM; Sukkar, MB; Sonvico, F
2017-04-21The effect of non-specific tight junction modulators on the transepithelial transport of poorly permeable drugs across airway epithelial cellsGhadiri, M; Young, PM; Jarolimek, W; Grau, GER; Oliver, BGG; Traini, D
2016-11-16Resveratrol solid lipid microparticles as dry powder formulation for nasal delivery, characterization and in vitro deposition studyMartignoni, I; Trotta, V; Lee, WH; Loo, CY; Pozzoli, M; Young, PM; Scalia, S; Traini, D
2016-10-02Dry powder nasal drug delivery: challenges, opportunities and a study of the commercial Teijin Puvlizer Rhinocort device and formulationPozzoli, M; Rogueda, P; Zhu, B; Smith, T; Young, PM; Traini, D; Sonvico, F
2016-10-01Application of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal productsPozzoli, M; Ong, HX; Morgan, L; Sukkar, M; Traini, D; Young, PM; Sonvico, F
2016-03-30Combination of Silver Nanoparticles and Curcumin Nanoparticles for Enhanced Anti-biofilm ActivitiesLoo, CY; Rohanizadeh, R; Young, PM; Traini, D; Cavaliere, R; Whitchurch, CB; Lee, WH